ProteLight Pharma
Latest round
- Series D
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 5
About ProteLight Pharma
, trading as ProteLight Pharma is a biomedical technology company focusing on R&D and production of polypeptide and chemical drugs. The company focuses on innovative drug development, with a pipeline of first-in-class peptide drugs targeting anti-infection and anti-cancer indications. It holds numerous patents, including PCT international patents and US/EU invention patents. Revenue is generated from sales of innovative peptide drugs, licensing intellectual property, and providing R&D services for pharmaceutical partners.
Who invested in ProteLight Pharma
5 investors across 2 rounds
See all investors in ProteLight Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ProteLight Pharma
Who invested in ProteLight Pharma?
ProteLight Pharma has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ProteLight Pharma raised?
ProteLight Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did ProteLight Pharma last raise money?
ProteLight Pharma's most recent round on record is a Series D, in Jan 2026.
What does ProteLight Pharma do?
, trading as ProteLight Pharma is a biomedical technology company focusing on R&D and production of polypeptide and chemical drugs.
Where is ProteLight Pharma headquartered?
ProteLight Pharma is headquartered in Wuxi, China.
Which VCs invest in companies like ProteLight Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at ProteLight Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like ProteLight Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.